Ryan Watts is President and Chief Executive Officer of Denali Therapeutics Inc. (DNLI). The company reported total compensation of $4,751,515 for fiscal year 2025.
| Salary | $718,000 |
|---|---|
| Bonus | $676,706 |
| Stock awards | $1,151,867 |
| Option awards | $2,180,003 |
| Non-equity incentive plan | $0 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $24,939 |
| Total | $4,751,515 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Denali Therapeutics Inc. filed April 21, 2026, accession 0001714899-26-000054.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President and Chief Executive Officer | $718,000 | $676,706 | $1,151,867 | $2,180,003 | $0 | $0 | $24,939 | $4,751,515 |
| FY2024 | President and Chief Executive Officer | $690,100 | $627,969 | $1,819,942 | $3,405,851 | — | — | $13,800 | $6,557,662 |
| FY2023 | President and Chief Executive Officer | $670,000 | $462,289 | $2,272,291 | $4,461,487 | — | — | $13,200 | $7,879,267 |
Totals as disclosed in each year's own compensation disclosure for Denali Therapeutics Inc..
| Peer-group chief executive median | $7,756,261 |
|---|---|
| Difference from that median | $-3,004,746 |
| Percentile within the disclosed peer group | 23rd |
| Peers with a disclosed figure | 21 |
Medians and percentiles are computed across the peer group Denali Therapeutics Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Ryan Watts this page | President and Chief Executive Officer | $4,751,515 |
| Alexander Schuth | Chief Operating and Financial Officer and Secretary | $4,258,045 |
| Carole Ho | Chief Medical Officer and Head of Development (until November 14, 2025) | $3,828,870 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Denali Therapeutics Inc. compensation brief.
Ryan Watts's compensation sits inside Denali Therapeutics Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.